共查询到20条相似文献,搜索用时 62 毫秒
1.
Immunosenescence and infectious diseases 总被引:6,自引:0,他引:6
Ginaldi L Loreto MF Corsi MP Modesti M De Martinis M 《Microbes and infection / Institut Pasteur》2001,3(10):851-857
Infectious diseases are major causes, with malignancies, of morbidity and mortality in the elderly. Increased susceptibility to infections may result from underlying dysfunction of an aged immune system; moreover, inappropriate immunologic functions associated with aging can determine an insufficient response to vaccines. Impairments of cellular, humoral and innate immunity in the elderly, contributing to increased incidence of infectious diseases, are discussed in this review. 相似文献
2.
3.
Salvatrice Mancuso Melania Carlisi Marco Santoro Mariasanta Napolitano Simona Raso Sergio Siragusa 《Immunity & ageing : I & A》2018,15(1):22
One of the most important determinants of aging-related changes is a complex biological process emerged recently and called “immunosenescence”. Immunosenescence refers to the inability of an aging immune system to produce an appropriate and effective response to challenge. This immune dysregulation may manifest as increased susceptibility to infection, cancer, autoimmune disease, and vaccine failure. At present, the relationship between immunosenescence and lymphoma in elderly patients is not defined in a satisfactory way.This review presents a brief overview of the interplay between aging, cancer and lymphoma, and the key topic of immunosenescence is addressed in the context of two main lymphoma groups, namely Non Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL). Epstein Barr Virus (EBV) plays a central role in the onset of neoplastic lymphoproliferation associated with immunological changes in aging, although the pathophysiology varies vastly among different disease entities. The interaction between immune dysfunction, immunosenescence and Epstein Barr Virus (EBV) infection appears to differ between NHL and HL, as well as between NHL subtypes. 相似文献
4.
The problems associated with the ageing immune system and vaccination were discussed recently at an international workshop
at the Jenner Institute for Vaccine Research, Compton, UK, 6–7 October, 2005. This is a commentary on that session. The meeting
included discussions on T and B cell differentiation and ageing, as well as dendritic cell and neutrophil data, with the emphasis
on T cell immunosenescence, perceived as the most important hindrance to satisfactory responses to vaccines in the elderly.
The main questions to be addressed in this context are the reasons for dysfunctionality of T cells in the elderly and what
to do to improve T cell function. Several of the major reasons for poor T cell responses in the elderly were discussed; however,
many important questions remain: The next meeting at the Jenner Institute may already be able to provide some of the answers
to these questions, which have serious implications for public health issues in increasingly elderly populations. 相似文献
5.
Giuseppina Campisi Martina Chiappelli Massimo De Martinis Vito Franco Lia Ginaldi Rosario Guiglia Federico Licastro Domenico Lio 《Immunity & ageing : I & A》2009,6(1):12-9
A Symposium regarding the Pathophysiology of Successful and Unsuccessful Ageing was held in Palermo, Italy on 7-8 April 2009. Three lectures from that Symposium by G. Campisi, L. Ginaldi and F. Licastro
are here summarized. Ageing is a complex process which negatively impacts on the development of various bodily systems and
its ability to function. A long life in a healthy, vigorous, youthful body has always been one of humanity's greatest dreams.
Thus, a better understanding of the pathophysiology of age-related diseases is urgently required to improve our understanding
of maintaining good health in the elderly and to program possible therapeutic intervention. 相似文献
6.
7.
Mauro Provinciali 《Cancer immunology, immunotherapy : CII》2009,58(12):1959-1967
Experimental and clinical data demonstrate that ageing is associated with the gradual deterioration of the immune system,
generally referred to as immunosenescence. Age-related immune dysfunction may have an impact not only on the incidence of
cancer, but also on the preventive and therapeutic approaches, which are based on immune system activation. Over the last
few years the use of immunological measures to prevent cancer in experimental mouse models involving preimmunisation with
new vaccines against even a poor or apparently non-immunogenic tumour has yielded worse outcomes in older age than in young
adults. Different mechanisms, which may be due to age-related numerical or functional dysfunction of immune cells and/or to
tumour microenvironmental changes, could be responsible for this defect. This review summarises the impact of immunosenescence
on the effectiveness of cancer vaccines, knowledge of cancer immunisation in old age and the potential mechanisms implicated
in the poorer effectiveness of anticancer immune-based approaches in advanced age. Several approaches to, and possibilities
of correcting the low effectiveness of immunisation procedures in old age are described. 相似文献
8.
The proportion of elderly people rises in the developed countries. The increased susceptibility of the elderly to infectious diseases is caused by immune dysfunction, especially T cell functional decline. Age-related hematopoietic stem cells deviate from lymphoid lineage to myeloid lineage. Thymus shrinks early in life, which is followed by the decline of na?ve T cells. T-cell receptor repertoire diversity declines by aging, which is caused by cytomegalovirus-driven T cell clonal expansion. Functional decline of B cell induces antibody affinity declines by aging. Many effector functions including phagocytosis of myeloid cells are down regulated by aging. The studies of aging of myeloid cells have some controversial results. Although M1 macrophages have been shown to be replaced by antiinflammatory(M2) macrophages by advanced age, many human studies showed that pro-inflammatory cytokines are elevated in older human. To solve this discrepancy here we divide age-related pathological changes into two categories. One is an aging of immune cell itself. Second is involvement of immune cells to age-related pathological changes. Cellular senescence and damaged cells in aged tissue recruit pro-inflammatory M1 macrophages, which produce pro-inflammatory cytokines and proceed to agerelated diseases. Underlying biochemical and metabolic studies will open nutritional treatment. 相似文献
9.
Jacques M Mathieu John Schloendorn Bruce E Rittmann Pedro JJ Alvarez 《Microbial cell factories》2009,8(1):21-18
Catabolic insufficiency in humans leads to the gradual accumulation of a number of pathogenic compounds associated with age-related
diseases, including atherosclerosis, Alzheimer's disease, and macular degeneration. Removal of these compounds is a widely
researched therapeutic option, but the use of antibodies and endogenous human enzymes has failed to produce effective treatments,
and may pose risks to cellular homeostasis. Another alternative is "medical bioremediation," the use of microbial enzymes
to augment missing catabolic functions. The microbial genetic diversity in most natural environments provides a resource that
can be mined for enzymes capable of degrading just about any energy-rich organic compound. This review discusses targets for
biodegradation, the identification of candidate microbial enzymes, and enzyme-delivery methods. 相似文献
10.
A. M. Vaiserman V. P. Voitenko L. V. Mekhova 《Russian Journal of Developmental Biology》2011,42(1):25-42
Many studies have shown that organism is mostly sensitive to different influences in pre- and postnatal periods of ontogenesis.
During the critical periods of development, these influences induce changes in the organism that relate to ontogenetic plasticity
and lead to permanent changes in structure and function of different organs and systems of the organism. It is suggested that
the main molecular mechanisms of so-called “ontogenetic programming” are based on changes that occur on the epigenetic level,
including changes in the genetic expression not connected with modifications of DNA structure. The present review deals with
experimental and epidemiologic evidences of the role of epigenetic processes in aging and determination of susceptibility
to some age-related diseases, such as cancer, cardiovascular and neurodegenerative diseases, and insulin-independent diabetes. 相似文献
11.
Exotic viral diseases 总被引:1,自引:0,他引:1
W R Dowdle 《The Yale journal of biology and medicine》1980,53(1):109-115
Marburg virus disease, Lassa fever, monkeypox, and Ebola virus diseases of humans have all been recognized since 1967. These are examples of some of the exotic virus diseases which through importation may present a potential public health problem in the United States. Some of these viruses are also highly hazardous to laboratory and medical personnel. This paper is a review of the general characteristics, the epidemiology, and laboratory diagnosis of the exotic viruses which have been described during the last 25 years. 相似文献
12.
13.
Floyd RA 《Aging cell》2006,5(1):51-57
Age-related diseases deprive individuals of a higher quality of life and therefore therapeutics for their treatment provide significant potential. An overview of the observations of nitrones as potential therapeutics in several age-related diseases is presented. Treatment of acute ischemic stroke is one condition where a nitrone (NXY-059) is in late phase 3 clinical trials now. Also presented is a summary of the most recent work we have accomplished on the anticancer activity of the nitrones in a hepatocellular carcinoma. The mechanistic basis of action of these compounds in several animal models is not yet understood at the molecular levels; however, it does appear clear that their anti-inflammatory properties are central to their action, which is based on their ability to down-regulate exacerbated signal transduction processes. 相似文献
14.
15.
《Trends in molecular medicine》2023,29(2):99-111
The beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) has long been considered a conventional target for Alzheimer’s disease (AD). Unfortunately, AD clinical trials of most BACE1 inhibitors were discontinued due to ineffective cognitive improvement or safety challenges. Recent studies investigating the involvement of BACE1 in metabolic, vascular, and immune functions have indicated a role in aging, diabetes, hypertension, and cancer. These novel BACE1 functions have helped to identify new ‘druggable’ targets for BACE1 against aging comorbidities. In this review, we discuss BACE1 regulation during aging, and then provide recent insights into its enzymatic and nonenzymatic involvement in aging and age-related diseases. Our study not only proposes the perspective of BACE1’s actions in various systems, but also provides new directions for using BACE1 inhibitors and modulators to delay aging and to treat age-related diseases. 相似文献
16.
Until 20 years ago the only chronic viral diseases known were those considered to be confined to the nervous system. As a result of recent advances in epidemiology, molecular biology and immunology, new viral diseases have been recognized and their clinical features and pathogenesis elucidated. Chronic disease may result from infection with the hepatitis B and D viruses and whatever agent or agents cause hepatitis non-A, non-B, the herpesviruses, Epstein-Barr virus, cytomegalovirus and human T-lymphotropic virus type III. These diseases have common features, including long-term or even lifetime asymptomatic carriage, viremia, with virus free in the plasma or attached to circulating mononuclear cells, presence of virus in body secretions, irreversible tissue injury in target organs and oncogenic potential. New information on these diseases is reviewed. Other chronic diseases for which the cause is currently unknown may eventually prove to be due to viral infection. In addition, vaccines may be developed for prophylaxis of some chronic viral diseases and associated malignant diseases. 相似文献
17.
18.
Telomeres as biomarkers for ageing and age-related diseases 总被引:4,自引:0,他引:4
Telomeres in telomerase-negative cells shorten during DNA replication in vitro due to numerous causes including the inability of DNA polymerases to fully copy the lagging strand, DNA end processing and random damage, often caused by oxidative stress. Short telomeres activate replicative senescence, an irreversible cell cycle arrest. Thus, telomere length is an indicator of replicative history, of the probability of cell senescence, and of the cumulative history of oxidative stress. Telomeres in most human cells shorten during ageing in vivo as well, suggesting that telomere length could be a biomarker of ageing and age-related morbidity. There are two distinct possibilities: First, in a tissue-specific fashion, short telomeres might indicate senescence of (stem) cells, and this might contribute to age-related functional attenuation in this tissue. Second, short telomeres in one tissue might cause systemic effects or might simply indicate a history of high stress and damage in the individual and could thus act as risk markers for age-related disease residing in a completely different tissue. In recent years, data have been published to support both approaches, and we will review these. While they together paint a fairly promising picture, it needs to be pointed out that until now most of the evidence is correlative, that much of it comes from underpowered studies, and that causal evidence for essential pathways, for instance for the impact of cell senescence on tissue ageing in vivo, is still very weak. 相似文献
19.
Pawelec G Koch S Griesemann H Rehbein A Hähnel K Gouttefangeas C 《Cancer immunology, immunotherapy : CII》2006,55(8):981-986
There are good arguments for suggesting that two seminal papers published 50 years ago can be taken as the beginning of modern tumour immunology. These papers by R. Baldwin, “Immunity to transplanted tumour: the effect of tumour extracts on the growth of homologous tumours in rats” and “Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of the implanted tumours” (Br J Cancer 9:646–51 and 652–657, 1955) showed that once tumours are established, they and their products can be recognised by the adaptive immune system and rejected. However, the tumour normally co-evolves with immunity, like a parasite, rather than being suddenly introduced as in these, and many other, experimental models. Dynamics of this co-evolution are illustrated by findings that inflammation enhances tumorigenicity, yet is important to enable T cells to respond properly to tumour antigen and exert anti-tumour effects. The important thing is to maintain the balance between effective anti-tumour immunity and tumour escape and/or stimulatory mechanisms. Tumours almost always co-exist with immune defence systems over extended periods and interact chronically with T cells. The effect of this is potentially similar to other situations of chronic antigenic stress, particularly lifelong persistent virus infection, most strikingly, CMV infection. The questions briefly explored in this symposium paper are what happens when T lymphocyte clones are chronically stimulated by antigen which is not or cannot be eliminated? What are the similarities and differences between chronic antigenic stimulation by tumour antigen versus CMV antigen? What can we learn in one system which may illuminate the other? 相似文献